Evidence map›Paper›PMID 23850635›Full record

ArticleJournal of autoimmunity2013

Distinct genetic control of autoimmune neuropathy and diabetes in the non-obese diabetic background.

Hélène Bour-Jordan, Heather L Thompson, Jennifer R Giampaolo, Dan Davini, Wendy Rosenthal, Jeffrey A Bluestone

Open access · hybridAbstract read
In one paragraph

Article in Journal of autoimmunity, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. The NOD Mouse Beyond Autoimmune Diabetes.Frontiers in immunology · 2022
    Review
  5. Review
  6. Transient Depletion of Foxp3Frontiers in immunology · 2021
    Article
  7. Review
  8. Article
  9. Article
  10. Peripheral Neuropathy in Mouse Models of Diabetes.Current protocols in mouse biology · 2016
    Review
  11. Review
  12. Alternatives to the Streptozotocin-Diabetic Rodent.International review of neurobiology · 2016
    Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Hélène Bour-JordanUniversity of California in San Francisco, 513 Parnassus Avenue, Box 0400, San Francisco, CA 94143-0400, USA.
Heather L Thompson
Jennifer R Giampaolo
Dan Davini
Wendy Rosenthal
Jeffrey A Bluestone
University of California, San Francisco · US

Funding

VIRAL ONCOLOGY CORE FACILITYP30CA014599 · NCI · UNIVERSITY OF CHICAGO · PI MARK W. LINGEN · 1985 to 2026
$122.1M
Research BaseP30DK063720 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KRUMMEL, MATTHEW F · 2003 to 2019
$21.8M
Spontaneous Autoimmune Model of Peripheral NeuropathyR01AI050834 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BLUESTONE, JEFFREY A · 2002 to 2011
$3.1M
IMMUNOMODULATION OF TRANSPLANT REJECTION BY ANTI-CD3 MABR37AI046643 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BLUESTONE, JEFFREY A · 2000 to 2009
$2.5M
NCI NIH HHS P30 CA014599NIAID NIH HHS R01 AI050834NIAID NIH HHS R37 AI046643NIDDK NIH HHS P30 DK063720
6 · The paper itself

Abstract

The non-obese diabetic (NOD) mouse is susceptible to the development of autoimmune diabetes but also multiple other autoimmune diseases. Over twenty susceptibility loci linked to diabetes have been identified in NOD mice and progress has been made in the definition of candidate genes at many of these loci (termed Idd for insulin-dependent diabetes). The susceptibility to multiple autoimmune diseases in the NOD background is a unique opportunity to examine susceptibility genes that confer a general propensity for autoimmunity versus susceptibility genes that control individual autoimmune diseases. We previously showed that NOD mice deficient for the costimulatory molecule B7-2 (NOD-B7-2KO mice) were protected from diabetes but spontaneously developed an autoimmune peripheral neuropathy. Here, we took advantage of multiple NOD mouse strains congenic for Idd loci to test the role of these Idd loci the development of neuropathy and determine if B6 alleles at Idd loci that are protective for diabetes will also be for neuropathy. Thus, we generated NOD-B7-2KO strains congenic at Idd loci and examined the development of neuritis and clinical neuropathy. We found that the NOD-H-2(g7) MHC region is necessary for development of neuropathy in NOD-B7-2KO mice. In contrast, other Idd loci that significantly protect from diabetes did not affect neuropathy when considered individually. However, we found potent genetic interactions of some Idd loci that provided almost complete protection from neuritis and clinical neuropathy. In addition, defective immunoregulation by Tregs could supersede protection by some, but not other, Idd loci in a tissue-specific manner in a model where neuropathy and diabetes occurred concomitantly. Thus, our study helps identify Idd loci that control tissue-specific disease or confer general susceptibility to autoimmunity, and brings insight to the Treg-dependence of autoimmune processes influenced by given Idd region in the NOD background.

Indexed as

Genetic LociAllelesAnimalsB7-2 AntigenCells, CulturedDiabetes Mellitus, Type 1FemaleGenetic Predisposition to DiseaseGuillain-Barre SyndromeHistocompatibility Antigens Class IIInterferon-gammaMaleMiceMice, CongenicMice, Inbred C57BLMice, Inbred NODB7-2 AntigenHistocompatibility Antigens Class III-A g7 antigenInterferon-gammaAutoimmunityDiabetesIdd lociNOD-B7-2KO micePeripheral neuropathyTregs

Identifiers

PMID23850635
PMCPMC4156399
OpenAlexW1972470155

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.